Page last updated: 2024-11-04

sulfadiazine and Diseases, Metabolic

sulfadiazine has been researched along with Diseases, Metabolic in 2 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Shao, Z1
Wang, S1
Liu, N1
Wang, W1
Zhu, L1
Sekas, G1
Paul, HS1

Other Studies

2 other studies available for sulfadiazine and Diseases, Metabolic

ArticleYear
Interactions between sulfonamide homologues and glycosyltransferase induced metabolic disorders in rice (Oryza sativa L.).
    Environmental pollution (Barking, Essex : 1987), 2023, Nov-01, Volume: 336

    Topics: Glycosyltransferases; Metabolic Diseases; Molecular Docking Simulation; Oryza; Sugars; Sulfadiazine;

2023
Hyperammonemia and carnitine deficiency in a patient receiving sulfadiazine and pyrimethamine.
    The American journal of medicine, 1993, Volume: 95, Issue:1

    Topics: Adult; Ammonia; Carnitine; Drug Therapy, Combination; Humans; Male; Metabolic Diseases; Pyrimethamin

1993